Solvay S.A.
Solvay’s polymer membranes technology will be a key element in hydrogen market
Brussels, January 13, 2021
Solvay has launched a hydrogen platform that will bring together all the innovative material and chemical solutions the Group has to offer to advance the emerging hydrogen economy. At the heart of the platform is Solvay’s membrane technology (ion conducting polymer), which constitutes a necessary component in the process of hydrogen production.
By creating this platform, Solvay is increasing its resources dedicated to this emerging market, including efforts in research and innovation. As from this year, Solvay is fully dedicating teams involving research, engineering, sales and marketing working together in crafting Solvay’s added value to the future hydrogen market.
Together with its membrane technology, under the brand Aquivion® that will be a key contributor to the electrolyser and fuel cells markets, Solvay also intends to bring other hydrogen applications and components to the market, such as hydrogen tanks.
“The hydrogen economy has taken-off, and with our new hydrogen platform, we are partnering with our customers in the electrolyser and fuel cells space to make it happen,” said Solvay CEO Ilham Kadri. “Green hydrogen will be one of the most competitive low carbon solutions for transportation applications in the near future and I’m proud that Solvay’s membrane technology will be a key element in the transition towards cleaner mobility, helping the fight against global climate change.”
As part of this commitment, Solvay has also joined the Hydrogen Council, a global CEO-led initiative that brings together leading companies with a united vision and long-term ambition for hydrogen to foster the clean energy transition. Solvay’s hydrogen platform is integral to the Group’s One Planet initiative, which includes ten measurable commitments to achieve the SDGs across three focus areas: climate, resources and better life.
Background
Solvay has been researching and developing its ionomer technology for the past twenty years in preparation for the development of hydrogen technology. Solvay’s technology has demonstrated its value proposition with customers; the company has multiple qualifications underway with sizable sales potential in the next few years.
While lithium-ion batteries have emerged as the preferred solution to make the automotive sector more sustainable, this is not enough as they do not cover all needs related to the necessary decarbonization to make transportation truly sustainable. Hydrogen is poised to fill that gap.
Production of green hydrogen via water electrolysis is expected to reach more than 100GW of global capacity by 2030, while the global fleet of fuel cell electric vehicles - ranging from large passenger cars to heavy-duty commercial vehicles, trucks, buses and even trains - is forecasted to reach several million vehicles by 2030.
Clean hydrogen fuel is a key component of the EU's Green Deal, as it is a recognized technology needed to support ambitions towards an ecological and sustainable energy transition. Public support for hydrogen is increasing exponentially, with USD 10 billion of post-Covid19 stimulus being dedicated (mostly in Europe and APAC) to green hydrogen R&D and infrastructure deployment.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Biotalys NV18.9.2025 07:00:00 CEST | Press release
Biotalys Reports Half-Year 2025 Financial Results and Business Highlights
F. Hoffmann-La Roche Ltd18.9.2025 07:00:00 CEST | Press release
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH
Ascom Holding AG18.9.2025 06:30:00 CEST | Press release
Michael Reitermann takes over the operational leadership of the Ascom Group as Delegate of the Board of Directors and interim CEO
Novo Nordisk A/S17.9.2025 23:05:02 CEST | Press release
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
Biogen Inc.17.9.2025 22:30:05 CEST | Press release
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom